Daniela Pugliese

34PUBLICATIONS
147CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Rheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 24, 2026
Pancreatic Hyperenzymemia in Inflammatory Bowel Disease: Clinical Characterization and Outcomes from the European PANDORA Registry.

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Jan 28, 2026
Treat-to-Target in Ulcerative Colitis: How Soon Is Now?

Laura Parisio, Giuseppe Cuccia, Giuseppe Privitera

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

Pageof 6